William Blair Downgrades Catalent (CTLT) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Nephron Double Upgrades Catalent (CTLT) to Buy, 'The Best Activist Candidate'
April 14, 2023 10:37 AM EDTNephron analyst Jack Meehan upgraded Catalent (NYSE: CTLT) from Sell to Buy.
"The Best Activist Candidate in Life Sciences"For an analyst ratings summary and ratings history on Catalent click here. For more ratings news on Catalent click here.
Shares of Catalent closed at $63.31 yesterday.
... More